Skip to main content
OpenTrials
Completed

NCT Number: NCT00848757

Changing Lifestyles for Better Health

The purpose of this research collaboration between Dr. William Tamborlane, Deputy Directory of the Yale Center for Clinical Investigation (YCCI) and Fair Haven Community Health Center's (FHCHC) Diabetes Prevention Team is to determine the efficacy of an intensive life-style intervention (ILI) program that has been developed and implemented at the FHCHC to prevent the development of diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Fair Haven Community Health Center

New Haven, Connecticut, 06513, United States

About this study

This project is a clinical outcome study that merges the expertise of a senior Yale clinical investigator, the clinical and translational research resources of YCCI, the clinical and community expertise of the FHCHC Diabetes Team, and the high-need patient population of FHCHC. In addition to determining the efficacy and cost-effectiveness of an ILI for diabetes prevention in an inner-city community health center setting, this project will evaluate the effectiveness of pooling academic expertise with direct clinical services to disadvantaged, at-risk populations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

In order to be eligible for this study, the following criteria must be met:

  • Subjects must be willing to travel to the clinic for all regularly scheduled study visits, and to the lifestyle intervention program site for the ILI (the John Martinez School).
  • Subjects must have had a 2 hour 75 gram Oral Glucose Tolerance Test (OGTT) with fasting glucose between 100 and 126, or 2 hour glucose between 140 and 200 mg/dl in order to participate in this study within the 4 months prior to enrollment.
  • Willingness to undergo fasting blood testing: HOMA-IR, fasting lipid profile (including total cholesterol, HDL, LDL cholesterol and triglycerides) at the beginning of the study (if not previously obtained with the OGTT) and repeated at 12 months.
  • Subjects must have no medical contraindications to exercise or dieting.

Exclusion criteria

  • Subjects will be excluded from the study if they have diabetes or other serious medical or psychiatric condition that would preclude participation in the ILI program.
  • Subjects will be excluded if they are taking medications that potentially cause significant weight gain or weight loss (including prescription medication, over the counter medication, or herbal supplements)..
  • Women who are pregnant or planning to become pregnant will not be enrolled in this study.
  • Any behavioral or psychosocial issue that will interfere with the subject's completion of the program, including an eating disorder will prohibit subjects from participating in this study.
  • Subjects cannot participate if they have concurrent membership in a comprehensive weight management program.

Treatment and study plan

Intensive lifestyle intervention

Behavioral

Women with pre-diabetes randomized to the ILI will attend an intensive 12-week group program of nutritional education, diet, behavior modification and structured exercise, which is based on the published curriculum from the DPP "Lifestyle Balance" program, but modified for a group format and to be more culturally and linguistically appropriate for this population.

Primary outcomes

  1. Change in Weight

    Time frame: Baseline and 12 Months

    The change is weight is reported from baseline to 12 months.

  2. Change in BMI

    Time frame: Baseline and 12 Months

    The change in BMI is reported from baseline to 12 months.

  3. Change in Percent Body Fat

    Time frame: Baseline and 12 Months

    Change in percent body fat is reported from baseline to 12 months. Body composition by body fat analyzer (TBF-300; Tanita,Arlington Heights, IL) was used.

  4. Change in Waist Circumference

    Time frame: Baseline and 12 Months

    Change in waist circumference was measured from baseline to 12 months

  5. Change in Blood Pressure

    Time frame: Baseline and 12 Months

    Change in blood pressure was measured from baseline to 12 months

Secondary outcomes

  1. Physical Activity Levels (Self-reported)

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Donaghue Medical Research Foundation

Registry information

Official study title

Changing Lifestyles for Better Health: A Model Program for Community Health Centers

Important dates

Study start
2009
Primary completion
2014
Study completion
2014
First posted
Feb 20, 2009
Registry last updated
May 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.